跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38,918 条关于
“HARMONi-3”
全部
38,918
临床试验
20,497
药物
4,747
机构
1,366
资讯
12,308
去年
Summit Therapeutics' Phase 3 HARMONi Trial Poised for Mid-2025 Readout in Duchenne Muscular Dystrophy
9个月前
Summit Therapeutics Submits BLA for Ivonescimab in EGFR-Mutated NSCLC as Analysts Spotlight Phase III Pipeline
去年
Summit Therapeutics Advances Ivonescimab Program with Pfizer Collaboration and Phase III Trial Progress in NSCLC
去年
Summit and Pfizer Partner to Evaluate Novel Cancer Therapy Combinations with Ivonescimab
4个月前
Summit Therapeutics Cancels $500M Share Sale Amid Ivonescimab Data Debate
10个月前
Pfizer Accelerates PF-08634404 Bispecific Development with Multiple Phase 3 Trials Following $1.25B 3SBio Deal
2年前
Summit Therapeutics Completes Enrollment in Phase III HARMONi Trial and Receives FDA Fast Track Designation for Ivonescimab
去年
Akeso Completes Patient Enrollment in Phase III Trial Comparing Ivonescimab for First-Line Squamous NSCLC Treatment
去年
Summit Therapeutics' Ivonescimab Shows Promise in NSCLC Trials
去年
Summit Therapeutics Completes Enrollment in Phase 3 HARMONi Trial for Ivonescimab in Lung Cancer
第 1 页,共 1231 页
上一页
下一页